Common Contracts
15 similar Employment Agreement contracts by Vermillion, Inc., Aspira Women's Health Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • March 21st, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Connecticut
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Sandra Milligan (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 16th, 2023 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Connecticut
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Torsten Hombeck (“Executive,” and together with the Company, the “Parties”) is effective as of June 15, 2023, or a date mutually agreeable to the parties (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Dr. Ryan Phan, PhD. (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Texas
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Minh Merchant (“Executive,” and together with the Company, the “Parties”) is effective as of March 28, 2023 (the “Effective Date”). The terms set forth herein shall supersede and replace in entirety the terms of employment set forth in that certain Employment Agreement between the Parties dated October 1, 2021.
EMPLOYMENT AGREEMENTEmployment Agreement • November 30th, 2022 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Marlene McLennan (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment, which commenced December 1, 2022 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 20th, 2017 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Robert Beechey (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 6th, 2015 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Fred Ferrara (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 13th, 2015 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Laura Miller (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 21st, 2014 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Holly Bauzon (“Executive,” and together with the Company, the “Parties”) is effective as of Executive’s first day of employment (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 17th, 2013 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Marian Sacco (“Executive,” and together with the Company, the “Parties”) is effective as of December 16, 2013 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2012 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and William Creech (“Executive,” and together with the Company, the “Parties”) is effective as of April 4, 2012 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2012 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Eric J. Schoen (“Executive,” and together with the Company, the “Parties”) is effective as of April 4, 2012 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 30th, 2010 • Vermillion, Inc. • Laboratory analytical instruments • Texas
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Gail Page (“Executive,” and together with the Company, the “Parties”) is effective as of September 28, 2010 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 30th, 2010 • Vermillion, Inc. • Laboratory analytical instruments • California
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Eric Fung (“Executive,” and together with the Company, the “Parties”) is effective as of September 28, 2010 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 22nd, 2010 • Vermillion, Inc. • Laboratory analytical instruments • California
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Vermillion, Inc., a Delaware corporation (the “Company”), and Sandra A. Gardiner (“Executive,” and together with the Company, the “Parties”) is effective as of April 19, 2010 (the “Effective Date”).
